NVO — Novo Nordisk

Median target
$45.5
calls from the last 12 months
Implied return
+13.2%
median target vs. price
Coverage
9 analysts · 10 calls
updated in the last 12 months
Consensus
0/9/00 net
Buy / Hold / Sell

Which analysts are behind NVO's consensus?

See every current rating, price target and the analysts' track records for Novo Nordisk — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 9 analysts with calls on NVO updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

NVO elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-09-10CongressKevin HernOK-OK01Salesince trade -8.7%, vs market +8.2%$1K–$15K
2026-08-31CongressKevin HernOK-OK01Salesince trade -11.3%, vs market +9.7%$1K–$15K
2025-10-31CongressLisa McClainMI-MI09Salesince trade -14.7%, vs market +25.9%$1K–$15K
2025-10-15CongressMarjorie Taylor GreeneGA-GA14Purchasesince trade -25.6%, vs market -39.7%$1K–$15K
2025-09-11CongressLisa McClainMI-MI09Purchasesince trade -22.3%, vs market -38.0%$1K–$15K
2025-08-28CongressMarjorie Taylor GreeneGA-GA14Purchasesince trade -24.8%, vs market -42.0%$1K–$15K
2025-08-04CongressScott Scott FranklinFL-FL18Purchasesince trade -12.6%, vs market -33.1%$15K–$50K
2025-08-04CongressScott Scott FranklinFL-FL18Purchasesince trade -12.6%, vs market -33.1%$1K–$15K
2025-08-04CongressScott Scott FranklinFL-FL18Purchasesince trade -12.6%, vs market -33.1%$1K–$15K
2025-08-04CongressLisa McClainMI-MI09Salesince trade -12.6%, vs market +33.1%$1K–$15K

More: congressional trades on NVO · insider activity · executive branch · trending